Moderna Stock Dips After Nasdaq-100 Index Removal and Amidst Ongoing Challenges
Moderna stock dipped after Nasdaq-100 removal amid declining COVID-19 vaccine sales and legal battles. The biotech company faces challenges but aims to diversify its pipeline beyond its COVID-19 vaccine.
Moderna Stock Dips After Nasdaq-100 Index Removal and Amidst Ongoing Challenges Read More »